Additionally, LINC00511 was also demonstrated to downregulate the expressions of KLF2 and LATS2 by promoting the binding of LSD1 to the promoter regions of LATS2 and KLF2 in lung cancer cells [33]. This evidence concerns the gene LATS2 and lung carcinoma.